Article Details
Retrieved on: 2022-07-10 14:32:21
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Vanguard Group Inc. now owns 4,491,530 shares of the biopharmaceutical company's stock worth $20,841,000 after purchasing an additional 730,091 shares ...
Article found on: www.defenseworld.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here